Judge rejects AstraZeneca’s challenge to Medicare drug price negotiations
Publishing timestamp: 2024-03-01 14:34:22
Summary
A federal judge rejected AstraZeneca's legal challenge to Medicare's new power to negotiate drug prices, a win for the Biden administration. The decision is part of a larger legal battle with the pharmaceutical industry over the constitutionality of these price talks.
Sentiment: MIXED
Keywords: business news, health care industry, pharmaceuticals, bristol-myers squibb co, business, astrazeneca plc, biotechnology, biotech and pharmaceuticals,